AbbVie Inc. ABBV
Price
Full chart with drawing tools and indicators
Valuation and ratios (P/E, margins, market value)
Price charts and figures by TradingView, shown in a sealed box: it cannot read this page, but TradingView may count your visit. Prices can be delayed.
Results from SEC filings
| Revenue | $61.2B | +9% | FY ending Dec 31, 2025 |
|---|---|---|---|
| Operating income | $15.1B | +65% | FY ending Dec 31, 2025 |
| Net income | $4.2B | -1% | FY ending Dec 31, 2025 |
| Earnings per share | $2.36 | -1% | FY ending Dec 31, 2025 |
| Research & development | $9.1B | -29% | FY ending Dec 31, 2025 |
| Cash from operations | $19.0B | +1% | FY ending Dec 31, 2025 |
| Capital spending | $1.2B | +25% | FY ending Dec 31, 2025 |
| Share buybacks | $980.0M | -43% | FY ending Dec 31, 2025 |
| Dividends paid | $11.7B | +6% | FY ending Dec 31, 2025 |
| Cash | $5.2B | -5% | FY ending Dec 31, 2025 |
| Long-term debt | $64.5B | -3% | FY ending Dec 31, 2025 |
| Shareholders' equity | $-3.3B | -198% | FY ending Dec 31, 2025 |
Insider trades
Last 12 months: 0 open-market buys ($0) and 4 sales ($18.9M) by officers, directors and big owners. These are exact: shares times the price each insider reported. Several sales by one person on one day are combined (average price).
| Insider | Trade | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Nicholas DonoghoeEVP, CHIEF BUS/STRAT OFFICER | Sold | 32,710 | $250.00 | $8.2M | Aug 14, 2026 |
| David Ryan PurdueSVP, Controller | Sold | 5,230 | $233.56 | $1.2M | Mar 4, 2026 |
| Perry C SiatisEVP, GC AND SECRETARY | Sold3 fills | 18,668 | $234.39 avg | $4.4M | Mar 2, 2026 |
| Perry C SiatisEVP, GC AND SECRETARY | Sold | 22,381 | $230.00 | $5.1M | Feb 25, 2026 |
Other insider moves (31): pay awards, option exercises, tax withholding, gifts
| Insider | Trade | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Nicholas DonoghoeEVP, CHIEF BUS/STRAT OFFICER | Option exercise | 32,710 | $79.02 | $2.6M | Aug 14, 2026 |
| Thomas J FalkDirector | Award | 1,118 | – | – | May 8, 2026 |
| Frederick H WaddellDirector | Award | 1,118 | – | – | May 8, 2026 |
| Rebecca B RobertsDirector | Award | 1,118 | – | – | May 8, 2026 |
| Edward J RappDirector | Award | 1,118 | – | – | May 8, 2026 |
| Susan E QuagginDirector | Award | 1,118 | – | – | May 8, 2026 |
| Melody B MeyerDirector | Award | 1,118 | – | – | May 8, 2026 |
| Brett J HartDirector | Award | 1,118 | – | – | May 8, 2026 |
| Thomas C FreymanDirector | Award | 1,118 | – | – | May 8, 2026 |
| Jennifer L. DavisDirector | Award | 1,118 | – | – | May 8, 2026 |
| William H.L. BurnsideDirector | Award | 1,118 | – | – | May 8, 2026 |
| Roxanne S AustinDirector | Award | 1,118 | – | – | May 8, 2026 |
| Robert A. MichaelCHAIRMAN OF THE BOARD AND CEO, Director | Tax withholding | 36,523 | $232.08 | $8.5M | Feb 27, 2026 |
| Jeffrey Ryan StewartEVP, CHIEF COMMERCIAL OFFICER | Tax withholding | 23,812 | $232.08 | $5.5M | Feb 27, 2026 |
| Scott T ReentsEVP, CHIEF FINANCIAL OFFICER | Tax withholding | 21,638 | $232.08 | $5.0M | Feb 27, 2026 |
| Azita Saleki-GerhardtEVP, CHIEF OPERATIONS OFFICER | Tax withholding | 16,309 | $232.08 | $3.8M | Feb 27, 2026 |
| Perry C SiatisEVP, GC AND SECRETARY | Tax withholding | 14,850 | $232.08 | $3.4M | Feb 27, 2026 |
| Nicholas DonoghoeEVP, CHIEF BUS/STRAT OFFICER | Tax withholding | 12,874 | $232.08 | $3.0M | Feb 27, 2026 |
| Roopal ThakkarEVP, R&D and CSO | Tax withholding | 8,037 | $232.08 | $1.9M | Feb 27, 2026 |
| David Ryan PurdueSVP, Controller | Tax withholding | 2,692 | $232.08 | $625K | Feb 27, 2026 |
| Demetris D CrumEVP, CHIEF HR OFFICER | Tax withholding | 1,594 | $232.08 | $370K | Feb 27, 2026 |
| Perry C SiatisEVP, GC AND SECRETARY | Option exercise3 fills | 22,381 | $172.62 avg | $3.9M | Feb 25, 2026 |
| Roopal ThakkarEVP, R&D and CSO | Award4 fills | 18,137 | – | – | Feb 18, 2026 |
| David Ryan PurdueSVP, Controller | Award4 fills | 6,071 | – | – | Feb 18, 2026 |
| Jeffrey Ryan StewartEVP, CHIEF COMMERCIAL OFFICER | Award4 fills | 53,749 | – | – | Feb 18, 2026 |
| Perry C SiatisEVP, GC AND SECRETARY | Award4 fills | 33,518 | – | – | Feb 18, 2026 |
| Azita Saleki-GerhardtEVP, CHIEF OPERATIONS OFFICER | Award4 fills | 36,811 | – | – | Feb 18, 2026 |
| Demetris D CrumEVP, CHIEF HR OFFICER | Award2 fills | 2,460 | – | – | Feb 18, 2026 |
| Nicholas DonoghoeEVP, CHIEF BUS/STRAT OFFICER | Award4 fills | 29,057 | – | – | Feb 18, 2026 |
| Scott T ReentsEVP, CHIEF FINANCIAL OFFICER | Award4 fills | 48,838 | – | – | Feb 18, 2026 |
| Robert A. MichaelCHIEF EXECUTIVE OFFICER, Director | Award4 fills | 82,439 | – | – | Feb 18, 2026 |
Trades by members of Congress
12 members reported 19 buys and 15 sales since Sep 26, 2024. Amounts are legal ranges, not exact figures.
| Member | Trade | Amount | Traded | Reported | Owner |
|---|---|---|---|---|---|
| Pete Sessions R | Sold | $15K–$50K | Sep 14, 2026 | Sep 18, 2026 | Self |
| Josh Gottheimer D | Sold | $1,001–$15K | May 5, 2026 | Jun 3, 2026 | Joint |
| Julie Johnson D | Sold | $1,001–$15K | Dec 18, 2025 | Jan 15, 2026 | Joint |
| Julia Letlow R | Sold | $1,001–$15K | Dec 8, 2025 | Jan 13, 2026 | Self |
| Julia Letlow R | Bought | $1,001–$15K | Apr 28, 2025 | Jan 13, 2026260 days later | Self |
| Julia Letlow R | Sold | $1,001–$15K | Jan 24, 2025 | Jan 13, 2026354 days later | Self |
| Julia Letlow R | Bought | $1,001–$15K | Oct 23, 2024 | Jan 13, 2026447 days later | Self |
| Julie Johnson D | Sold some | $1,001–$15K | Nov 13, 2025 | Dec 11, 2025 | Joint |
| Lisa C. McClain R | Sold | $1,001–$15K | Oct 31, 2025 | Nov 21, 2025 | Spouse |
| Lisa C. McClain R | Sold | $1,001–$15K | Oct 30, 2025 | Nov 21, 2025 | Spouse |
| Lisa C. McClain R | Bought | $1,001–$15K | Oct 30, 2025 | Nov 21, 2025 | Spouse |
| Julie Johnson D | Sold some | $1,001–$15K | Aug 14, 2025 | Sep 11, 2025 | Joint |
| Ritchie Torres D | Sold | $1,001–$15K | Jul 11, 2025 | Aug 20, 2025 | Self |
| Ritchie Torres D | Bought | $1,001–$15K | Sep 26, 2024 | Aug 20, 2025328 days later | Self |
| Marjorie Taylor Greene R | Bought | $1,001–$15K | Aug 4, 2025 | Aug 15, 2025 | Self |
| Lisa C. McClain R | Sold some | $1,001–$15K | Jul 22, 2025 | Aug 13, 2025 | Spouse |
| Lisa C. McClain R | Bought | $1,001–$15K | Jul 22, 2025 | Aug 13, 2025 | Spouse |
| Lisa C. McClain R | Bought | $1,001–$15K | Jun 17, 2025 | Aug 13, 202557 days later | Spouse |
| Josh Gottheimer D | Bought | $1,001–$15K | May 22, 2025 | Jun 11, 2025 | Joint |
| Robert P. Bresnahan, Jr. R | Bought | $1,001–$15K | May 15, 2025 | Jun 9, 2025 | Self |
| Josh Gottheimer D | Sold | $1,001–$15K | Apr 17, 2025 | May 14, 2025 | Joint |
| Josh Gottheimer D | Bought | $1,001–$15K | Apr 3, 2025 | May 14, 2025 | Joint |
| Josh Gottheimer D | Bought | $1,001–$15K | Apr 1, 2025 | May 14, 2025 | Joint |
| Jared Moskowitz D | Bought | $1,001–$15K | Apr 7, 2025 | May 9, 2025 | Self |
| Jefferson Shreve R | Sold | $50K–$100K | Apr 17, 2025 | May 8, 2025 | Self |
| Robert P. Bresnahan, Jr. R | Sold | $1,001–$15K | Apr 8, 2025 | May 8, 2025 | Self |
| Marjorie Taylor Greene R | Bought | $1,001–$15K | May 5, 2025 | May 6, 2025 | Self |
| Dwight Evans D | Sold some | $1,001–$15K | Apr 3, 2025 | Apr 17, 2025 | Self |
| Robert P. Bresnahan, Jr. R | Bought | $1,001–$15K | Feb 25, 2025 | Mar 27, 2025 | Self |
| Marjorie Taylor Greene R | Bought | $1,001–$15K | Mar 17, 2025 | Mar 19, 2025 | Self |
| Jefferson Shreve R | Bought | $50K–$100K | Feb 24, 2025 | Mar 9, 2025 | Self |
| Jared Moskowitz D | Bought | $1,001–$15K | Jan 15, 2025 | Feb 10, 2025 | Child |
| Jared Moskowitz D | Bought | $1,001–$15K | Jan 15, 2025 | Feb 10, 2025 | Self |
| Virginia Foxx R | Bought | $1,001–$15K | Dec 6, 2024 | Jan 6, 2025 | Self |
Latest SEC filings
- News filing: Executive or board change 8-K · Oct 15, 2026
- News filing: Quarterly results 8-K · Oct 5, 2026
- News filing: Public announcement (Reg FD) 8-K · Sep 3, 2026
- News filing: Other news 8-K · Aug 18, 2026
- Insider plans to sell 144 · Aug 14, 2026
- News filing: Other news 8-K · Aug 5, 2026
- Quarterly report 10-Q · Aug 3, 2026
- News filing: Quarterly results 8-K · Jul 31, 2026
- News filing: Quarterly results 8-K · Jul 6, 2026
- News filing: Public announcement (Reg FD) 8-K · Jun 22, 2026
- Insider plans to sell 144 · May 26, 2026
- News filing: Shareholder vote results 8-K · May 12, 2026
- Quarterly report 10-Q · May 8, 2026
- News filing: Quarterly results 8-K · Apr 29, 2026
- News filing: Quarterly results 8-K · Apr 3, 2026
- Shareholder meeting proxy DEF 14A · Mar 23, 2026
- Insider plans to sell 144 · Mar 6, 2026
- News filing: Other news 8-K · Mar 4, 2026
- Insider plans to sell 144 · Mar 2, 2026
- News filing: Other news 8-K · Feb 26, 2026
- Insider plans to sell 144 · Feb 25, 2026
- Annual report 10-K · Feb 20, 2026
- News filing: Quarterly results 8-K · Feb 4, 2026
- News filing: Quarterly results 8-K · Jan 7, 2026
- Quarterly report 10-Q · Nov 4, 2025
About AbbVie Inc.
Business description
- Industry
- Pharmaceutical Preparations
- Sector
- Life Sciences
- Headquarters
- North Chicago, IL
- Incorporated in
- DE
- Fiscal year ends
- December 31
- Exchange
- NYSE
- Filer size
- Large accelerated filer
- SEC company number (CIK)
- 1551152
Company figures and insider trades: U.S. Securities and Exchange Commission (EDGAR). Congress trades: Clerk of the U.S. House of Representatives. Nebula is not affiliated with either and this page is not investment advice.